Bhatt Padmanabh P.

CIK 00015392151 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001539215

Recent Transactions

50 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-12-18−1,500→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-12-18$44.44/sh−710→ 14,508 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-12-18+1,500→ 15,218 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-11-13+1,500→ 1,500 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-25$41.46/sh−581→ 13,718 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-08-25−1,250→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-25+1,250→ 14,299 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-08-07+1,250→ 1,250 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−575→ 13,279 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−335→ 13,854 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−575→ 12,704 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-23−1,250→ 2,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-23+1,250→ 14,189 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−750→ 750 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−1,250→ 3,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+750→ 11,689 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+1,250→ 12,939 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21+1,650→ 11,799 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21$39.15/sh−860→ 10,939 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-21−1,650→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-19+20,000→ 20,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-04$39.70/sh−9,477→ 10,149 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-04$29.61/sh+9,477→ 19,626 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-04−9,477→ 4,250 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-01-28$39.62/sh−700→ 10,149 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-01-28+1,650→ 1,650 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-01-28−700→ 9,477 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-01-28−700→ 13,727 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-01-28$29.61/sh+700→ 10,849 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-01-27$39.62/sh−2,573→ 10,149 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-01-27−2,573→ 10,177 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-01-27$29.61/sh+2,573→ 12,722 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-12-03−8,750→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-03$36.68/sh−12,745→ 9,679 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-03$25.30/sh+12,745→ 22,424 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-03$36.68/sh−8,750→ 9,679 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-03$23.99/sh+8,750→ 18,429 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-12-03−12,745→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-08-20−1,250→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-08-20$29.57/sh−572→ 9,679 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-08-20+1,250→ 10,251 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-08-01+1,250→ 1,250 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-03-21−14,491→ 12,745 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-03-21$35.31/sh−14,491→ 8,570 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-03-21$25.30/sh+14,491→ 23,061 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-03-20−400→ 27,236 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-03-20$35.31/sh−400→ 8,570 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-03-20$25.30/sh+400→ 8,970 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-03-19−12,364→ 27,636 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
Sr. VP of IP; CSO
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTCALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov